Adoptive Transfer of Tumor Specific T Cells from Allogeneic Donors Is Feasible, Effective and Safe Alternative to Autologous T Cell Based Tumor Immunotherapy. JMS 2014, 83 (1), 21-28. https://doi.org/10.20883/medical.e39.